KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Tax Provisions (2016 - 2026)

Idexx Laboratories has reported Tax Provisions over the past 17 years, most recently at $58.8 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 46.12% year-over-year to $58.8 million; the TTM value through Dec 2025 reached $264.7 million, up 19.26%, while the annual FY2025 figure was $264.7 million, 19.26% up from the prior year.
  • Tax Provisions for Q4 2025 was $58.8 million at Idexx Laboratories, down from $70.2 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $70.2 million in Q3 2025 and troughed at $29.1 million in Q4 2021.
  • A 5-year average of $52.1 million and a median of $53.4 million in 2022 define the central range for Tax Provisions.
  • Biggest five-year swings in Tax Provisions: skyrocketed 1074.82% in 2021 and later decreased 20.4% in 2022.
  • Year by year, Tax Provisions stood at $29.1 million in 2021, then soared by 40.86% to $41.0 million in 2022, then rose by 10.09% to $45.1 million in 2023, then dropped by 10.87% to $40.2 million in 2024, then surged by 46.12% to $58.8 million in 2025.
  • Business Quant data shows Tax Provisions for IDXX at $58.8 million in Q4 2025, $70.2 million in Q3 2025, and $68.4 million in Q2 2025.